Greenland Mines Ltd SEC filings GRMLW
Greenland Mines Ltd has 268 filings in SEC EDGAR's recent list, going back to Jan 31, 2022. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 3, 2026 | — |
| S-1 | Registration statement | Oct 26, 2026 | — |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2026 | Sep 28, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 424B5 | Prospectus supplement | Sep 28, 2026 | — |
| 8-K |
Current report
Material agreement
|
Sep 28, 2026 | Sep 23, 2026 |
| 424B5 | Prospectus supplement | Sep 23, 2026 | — |
| 8-K |
Current report
Material agreement
|
Sep 23, 2026 | Sep 21, 2026 |
| 424B5 | Prospectus supplement | Sep 23, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
|
Sep 4, 2026 | Sep 1, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 2, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 27, 2026 | Aug 26, 2026 |
| 424B5 | Prospectus supplement | Aug 27, 2026 | — |
| 424B5 | Prospectus supplement | Aug 25, 2026 | — |
| 4 | Insider transaction | Aug 25, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 24, 2026 | Aug 24, 2026 |
| 424B5 | Prospectus supplement | Aug 24, 2026 | — |
| 10-Q | Quarterly report | Aug 17, 2026 | Jun 30, 2026 |
| 10-Q/A | Amended quarterly report | Aug 14, 2026 | Mar 31, 2026 |
| 10-K/A | Amended annual report | Aug 14, 2026 | Dec 31, 2025 |
| NT 10-Q | Notification of late filing | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 10, 2026 | Aug 7, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jul 22, 2026 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Other events
|
Jul 23, 2026 | Jul 22, 2026 |
| 8-A12B | For registration of certain classes | Jul 23, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jul 21, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 20, 2026 | Jul 15, 2026 |
| 4 | Insider transaction | Jul 20, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jul 17, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Auditor change
|
Jul 8, 2026 | Jul 4, 2026 |
| 8-K |
Current report
Auditor change
|
Jun 29, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Jun 25, 2026 | Jun 18, 2026 |
| 144 | Notice of proposed sale | Jun 24, 2026 | — |
| DEF 14A | Proxy statement | Jun 22, 2026 | Jul 16, 2026 |
| 424B3 | Prospectus | Jun 22, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 22, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 17, 2026 | Jun 15, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 9, 2026 | Jun 9, 2026 |
| DEF 14A | Proxy statement | May 26, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Material agreement
|
May 21, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 20, 2026 | Mar 31, 2026 |
| 8-K/A | Amended current report | May 19, 2026 | Mar 4, 2026 |
| PRE 14A | Preliminary proxy statement | May 15, 2026 | May 15, 2026 |
| NT 10-Q | Notification of late filing | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2026 | May 13, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 22, 2026 | Apr 17, 2026 |
| S-8 POS | Registration statement | Apr 17, 2026 | — |
| 10-K | Annual report | Apr 1, 2026 | Dec 31, 2025 |
| NT 10-K | Notification of late filing | Apr 1, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 23, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Mar 16, 2026 | Mar 11, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 13, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Bylaw or fiscal year change
|
Mar 10, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Mar 2, 2026 | Feb 27, 2026 |
| 424B3 | Prospectus | Feb 24, 2026 | — |
| 8-K |
Current report
Material agreement
|
Feb 24, 2026 | Feb 19, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Feb 17, 2026 | Feb 17, 2026 |
| DEFR14A | Proxy statement | Jan 26, 2026 | — |
| DEF 14A | Proxy statement | Jan 23, 2026 | Feb 13, 2026 |
| PRE 14A | Preliminary proxy statement | Jan 12, 2026 | Jan 12, 2026 |
| EFFECT | Filing | Dec 12, 2025 | — |
| CORRESP | Letter to the SEC | Dec 10, 2025 | — |
| 4 | Insider transaction | Dec 10, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 8, 2025 | Dec 2, 2025 |
| S-1 | Registration statement | Dec 5, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| S-8 | Employee stock plan registration | Nov 6, 2025 | — |
| 424B3 | Prospectus | Sep 30, 2025 | — |
| 4 | Insider transaction | Sep 29, 2025 | Sep 25, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 25, 2025 | Sep 19, 2025 |
| 8-K |
Current report
Listing notice
|
Sep 25, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 25, 2025 |
| 10-Q | Quarterly report | Aug 18, 2025 | Jun 30, 2025 |
| NT 10-Q | Notification of late filing | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 12, 2025 | Aug 6, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 5, 2025 |
| 424B5 | Prospectus supplement | Jul 28, 2025 | — |
| 424B3 | Prospectus | Jul 28, 2025 | — |
| 424B3 | Prospectus | Jul 28, 2025 | — |
| EFFECT | Filing | Jul 25, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Jul 23, 2025 | Aug 26, 2024 |
| CORRESP | Letter to the SEC | Jul 22, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 22, 2025 | Jul 16, 2025 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jul 18, 2025 | Jul 14, 2025 |
| UPLOAD | Letter from the SEC | Jul 17, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 10, 2025 | Jul 10, 2025 |
| S-3 | Shelf registration | Jul 7, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 2, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 2, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 16, 2025 | Jun 16, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 13, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 11, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jun 10, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2025 | May 28, 2025 |
| PRE 14A | Preliminary proxy statement | May 28, 2025 | May 27, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| DEF 14A | Proxy statement | May 5, 2025 | May 28, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 21, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Other events
|
Apr 4, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement
|
Apr 1, 2025 | Mar 26, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 24, 2025 | Feb 14, 2025 |
| 424B3 | Prospectus | Feb 13, 2025 | — |
| EFFECT | Filing | Feb 10, 2025 | — |
| CORRESP | Letter to the SEC | Feb 7, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2025 | — |
| S-1 | Registration statement | Jan 30, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 24, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 10, 2024 | Dec 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 25, 2024 | Nov 19, 2024 |
| 10-Q | Quarterly report | Nov 19, 2024 | Sep 30, 2024 |
| NT 10-Q | Notification of late filing | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Agreement ended
|
Nov 13, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Auditor change
|
Oct 31, 2024 | Oct 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 31, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 21, 2024 | Oct 14, 2024 |
| 8-K |
Current report
Other events
|
Oct 2, 2024 | Sep 24, 2024 |
| 424B3 | Prospectus | Oct 1, 2024 | — |
| EFFECT | Filing | Sep 18, 2024 | — |
| CORRESP | Letter to the SEC | Sep 17, 2024 | — |
| CORRESP | Letter to the SEC | Sep 13, 2024 | — |
| S-1/A | Amended registration statement | Sep 13, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2024 | — |
| S-1 | Registration statement | Sep 5, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2024 | Aug 25, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 22, 2024 | Aug 15, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 22, 2024 | Aug 16, 2024 |
| 10-Q | Quarterly report | Aug 19, 2024 | Jun 30, 2024 |
| NT 10-Q | Notification of late filing | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 5, 2024 | Jul 30, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 3 | Initial insider ownership | Jul 1, 2024 | Jun 21, 2024 |
| SC 13G | Ownership over 5% (passive) | Jun 27, 2024 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
|
Jun 27, 2024 | Jun 21, 2024 |
| 25-NSE | Delisting notice | Jun 21, 2024 | — |
| 425 | Current report | Jun 20, 2024 | — |
| 8-K |
Current report
Other events
|
Jun 20, 2024 | Jun 20, 2024 |
| 425 | Current report | Jun 14, 2024 | — |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Other events
|
Jun 14, 2024 | Jun 13, 2024 |
| 425 | Current report | Jun 14, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 14, 2024 | Jun 13, 2024 |
| 10-Q | Quarterly report | May 23, 2024 | Mar 31, 2024 |
| NT 10-Q | Notification of late filing | May 15, 2024 | Mar 31, 2024 |
| 425 | Current report | May 10, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 10, 2024 | May 9, 2024 |
| 425 | Current report | Apr 18, 2024 | — |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Apr 18, 2024 | Apr 12, 2024 |
| 10-K | Annual report | Apr 17, 2024 | Dec 31, 2023 |
| 425 | Current report | Apr 12, 2024 | — |
| 8-K |
Current report
Other events
|
Apr 12, 2024 | Apr 8, 2024 |
| 425 | Current report | Apr 8, 2024 | — |
| 8-K |
Current report
Other events
|
Apr 5, 2024 | Apr 1, 2024 |
| NT 10-K | Notification of late filing | Apr 1, 2024 | Dec 31, 2023 |
| 425 | Current report | Mar 22, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 22, 2024 | Mar 22, 2024 |
| 425 | Current report | Mar 11, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 11, 2024 | Mar 8, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 22, 2024 | — |
| DEFM14A | Proxy statement | Feb 20, 2024 | — |
| 424B3 | Prospectus | Feb 16, 2024 | — |
| EFFECT | Filing | Feb 14, 2024 | — |
| S-4/A | Registration statement | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| CORRESP | Letter to the SEC | Feb 12, 2024 | — |
| S-4/A | Registration statement | Feb 12, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2024 | — |
| S-4/A | Registration statement | Feb 7, 2024 | — |
| S-4/A | Registration statement | Feb 1, 2024 | — |
| CORRESP | Letter to the SEC | Feb 1, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2024 | — |
| CORRESP | Letter to the SEC | Jan 3, 2024 | — |
| S-4/A | Registration statement | Jan 3, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2023 | — |
| CORRESP | Letter to the SEC | Dec 4, 2023 | — |
| S-4/A | Registration statement | Dec 4, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2023 | — |
| 10-Q | Quarterly report | Nov 17, 2023 | Sep 30, 2023 |
| NT 10-Q | Notification of late filing | Nov 15, 2023 | Sep 30, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GRML (Nasdaq), GRMLW (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Omaha, NE
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1907223
- Former names
- Klotho Neurosciences, Inc. (until Mar 10, 2026); ANEW Medical, Inc. (until Sep 18, 2024); Redwoods Acquisition Corp. (until Jun 21, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.